ARCHIVES

Research teams link response to Iressa to mutations in EGF receptor.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Interview With Screening Expert Barnett Kramer, PLCO Investigator

March 20, 2009

Clarification: Full Text Of ACS Guideline On Prostate Screening

January 30, 1998

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004